4:06 PM ET
8-K
Loan & Debt
Evofem Biosciences Debt Financing Update with Adjuvant Global Health Technology Fund, L.P.
Evofem Biosciences entered into a fifth amendment to its Securities Purchase Agreement with Adjuvant Global Health Technology Fund. The amendment extends the maturity date of outstanding convertible promissory notes to December 1, 2026, and removes certain affirmative covenants.
- Counterparty
- Adjuvant Global Health Technology Fund, L.P.
- Term
- through Dec 2026